3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
3
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
4
Gastrointestinal
2
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Prostatic Neoplasms
1306
Carcinoma, Renal Cell
660
Urinary Bladder Neoplasms
405
Carcinoma, Non-Small-Cell Lung
332
Neoplasms
301
Carcinoma, Transitional Cell
263
Breast Neoplasms
252
Ovarian Neoplasms
248
Melanoma
235
Colorectal Neoplasms
226
Neoplasm Metastasis
214
Kidney Neoplasms
200
Pancreatic Neoplasms
169
Stomach Neoplasms
162
Squamous Cell Carcinoma of Head and Neck
142
Lung Neoplasms
140
Uterine Cervical Neoplasms
122
Non-Muscle Invasive Bladder Neoplasms
118
Triple Negative Breast Neoplasms
111
Head and Neck Neoplasms
111
Endometrial Neoplasms
109
Esophageal Neoplasms
107
Carcinoma, Hepatocellular
97
Small Cell Lung Carcinoma
79
Sarcoma
75
Colonic Neoplasms
55
Urologic Neoplasms
53
Prostatic Neoplasms, Castration-Resistant
47
Liver Neoplasms
47
Carcinoma
43
Interventions
Quality of Life
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Immunotherapy
1
Drug Therapy
1
Biological Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Pharyngeal Neoplasms
×
Genitourinary
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled